Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea · Delayed Price · Currency is KRW 11,570
+330 (2.94%)
At close: Sep 8, 2025
KRX:000520 Market Cap
KRX:000520 has a market cap or net worth of 245.63 billion as of September 8, 2025. Its market cap has increased by 17.74% in one year.
Market Cap
245.63B
Enterprise Value
402.22B
Revenue
217.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,570.00
Market Cap Chart
Since August 30, 1995, KRX:000520's market cap has increased from 13.98B to 245.63B, an increase of 1,657.29%. That is a compound annual growth rate of 10.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 245.63B | -12.02% |
| Dec 30, 2024 | 279.17B | 188.10% |
| Dec 28, 2023 | 96.90B | -11.01% |
| Dec 29, 2022 | 108.89B | 2.33% |
| Dec 30, 2021 | 106.42B | -17.45% |
| Dec 30, 2020 | 128.91B | 0.33% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.31T |
| Celltrion | 37.23T |
| ALTEOGEN | 25.41T |
| Yuhan | 8,902.27B |
| SK Biopharmaceuticals | 8,551.81B |
| Peptron | 7,070.75B |
| PharmaResearch | 6,545.48B |
| ABL Bio | 5,621.23B |